GLAXO
Glaxosmithkline Pharmaceuticals Ltd
₹2,077.25
Glaxosmithkline Pharmaceuticals Ltd Dividend 2024 : Should Glaxosmithkline Pharmaceuticals Ltd be a part of your dividend portfolio?
Glaxosmithkline Pharmaceuticals Ltd is one of the most popular Basic Materials company in the world with a market capitalisation of ₹32,909.66Cr. Its share price is ₹2,077.25 as on 24 April,2024.
The dividend is a percentage of earnings paid out to shareholders. Last year, Glaxosmithkline Pharmaceuticals Ltd gave ₹32 for the full year, but should it be a part of your investments that give good dividends?
Key Highlights
- Basic Materials stocks do not always pay a dividend but as Glaxosmithkline Pharmaceuticals Ltd pays dividends to reward its shareholders.
- In the quarter ending March 2023, Glaxosmithkline Pharmaceuticals Ltd has declared dividend of ₹32 - translating a dividend yield of 1.54%.
Let's look at Glaxosmithkline Pharmaceuticals Ltd’s capacity to pay dividends and consider its valuation to determine its virtues as a dividend stock:
- Glaxosmithkline Pharmaceuticals Ltd’s revenue were ₹833.37Cr in the quarter ending December 2023. The revenue grew by 0.93% year on year basis since last quarter.
- Glaxosmithkline Pharmaceuticals Ltd’s profits were ₹45.72Cr in the quarter ending December 2023. The profits fell by -72.22% year on year basis since last quarter.
- Glaxosmithkline Pharmaceuticals Ltd’s dividend was ₹32 in the quarter ending March 2023.
Glaxosmithkline Pharmaceuticals Ltd Dividend related ratios:
- Last dividend date: 17/05/2023
- Current Dividend Yield: 1.54%
- Annual dividend payment: ₹32
History of Glaxosmithkline Pharmaceuticals Ltd's Dividend payments
| Ex/EFF DATE | TYPE | CASH AMOUNT | DECLARATION DATE | RECORD DATE |
|---|---|---|---|---|
30/06/2023 | CASH | ₹32 | 17/05/2023 | 30/06/2023 |
07/07/2022 | CASH | ₹30 | 16/05/2022 | 08/07/2022 |
07/07/2022 | CASH | ₹60 | 16/05/2022 | 08/07/2022 |
19/07/2021 | CASH | ₹30 | 18/05/2021 | 20/07/2021 |
17/07/2020 | CASH | ₹20 | 18/05/2020 | 20/07/2020 |
View More
